erythromycin has been researched along with ethambutol in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (35.71) | 18.7374 |
| 1990's | 4 (14.29) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 3 (10.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Gibbons, S; Paton, A; Skelton, BW; Stavri, M | 1 |
| Cartabuke, RH; Nguyen, HT; Nguyen, L; Ogwang, S; Singh, A; Wolff, KA | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Curry, J; Gibbons, S; Malkinson, JP; Rahman, MM; Shiu, WK; Stapleton, P; Zloh, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kimbel, KH | 1 |
| Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
| Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 1 |
| Labrousse, V; Rastogi, N | 1 |
| Andrzejczyk, Z; Janowiec, M; Szwedowicz, I | 1 |
| Brazeau, M; Marks, MI; Shapera, RM | 1 |
| Datta, JS; Raff, MJ | 1 |
| Crofton, JW; Schonell, ME; Stuart, AE; Wallace, A | 1 |
| Clark, J; Thomson, DS; Wallace, A | 1 |
| Fischer, P; Schilling, W | 1 |
| Hodges, GR; Snavely, SR | 1 |
| Flenley, DC | 1 |
| Bouveret, JP; Gerbeaux, J; Hanoteau, J; Houin, G; Tillement, JP | 1 |
| De Micco, P; Gevaudan, MJ | 1 |
| Baraia-Etxaburu, J; Ibarrola, M; Miguel Santamaría, J; Sánchez, R; Teira, R; Unzaga, J | 1 |
| Dziadek, J; Korycka-Machała, M; Rumijowska-Galewicz, A | 1 |
3 review(s) available for erythromycin and ethambutol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The neurotoxicity of antibacterial agents.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Cephalosporins; Chloramphenicol; Clindamycin; Colistin; Cranial Nerve Diseases; Dapsone; Erythromycin; Ethambutol; Humans; Lincomycin; Metronidazole; Nervous System Diseases; Neuromuscular Junction; Penicillins; Peripheral Nervous System Diseases; Polymyxin B; Sulfonamides; Tetracyclines; Vancomycin | 1984 |
New drugs in respiratory disorders: II.
Topics: Adult; Aged; Amantadine; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Cyclophosphamide; Drug Combinations; Erythromycin; Ethambutol; Humans; Metronidazole; Pyrazinamide; Respiratory Tract Diseases; Respiratory Tract Infections; Rifampin; Trimethoprim; Tuberculosis, Pulmonary | 1983 |
25 other study(ies) available for erythromycin and ethambutol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Antibacterial diterpenes from Plectranthus ernstii.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Diterpenes; Drug Resistance, Multiple; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Plectranthus; Stereoisomerism; United Kingdom | 2009 |
Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Western; Cyclic GMP-Dependent Protein Kinases; Drug Resistance, Microbial; Mycobacterium; Mycobacterium tuberculosis; Phagosomes; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Antibacterial acylphloroglucinols from Hypericum olympicum.
Topics: Anti-Bacterial Agents; Hypericum; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Phloroglucinol; Staphylococcus aureus | 2012 |
[Toxicological evaluation criteria (secondary action aspects)].
Topics: Anti-Infective Agents; Cephalosporins; Chloramphenicol; Erythromycin; Ethambutol; Gentamicins; Humans; Isoniazid; Lincomycin; Nalidixic Acid; Neomycin; Nitrofurantoin; Penicillins; Rifampin; Streptomycin; Sulfonamides; Tetracyclines | 1977 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Minocycline; Mycobacterium; Quinolones; Rifabutin; Rifamycins | 1991 |
Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.
Topics: Cell Division; Cells, Cultured; Clarithromycin; Drug Combinations; Erythromycin; Ethambutol; Microbial Sensitivity Tests; Microscopy, Electron; Mycobacterium avium; Rifampin | 1991 |
[Synergistic effects of davercin, rifampicin, ethambutol and isonicotinic acid hydrazide on selected standard strains of Mycobacterium in the in-vitro and in-vivo experiments].
Topics: Animals; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; In Vitro Techniques; Isoniazid; Mice; Mycobacterium; Mycobacterium Infections; Rifampin | 1988 |
Pediatric antimicrobial therapy. II.
Topics: Bacteria; Colistin; Drug Therapy; Erythromycin; Escherichia coli; Ethambutol; Gentamicins; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Pediatrics | 1973 |
Actinomycotic pleuropericarditis.
Topics: Actinomycosis; Aminosalicylic Acids; Cardiomegaly; Erythromycin; Ethambutol; Fusobacterium; Humans; Isoniazid; Male; Middle Aged; Pericardial Effusion; Pericarditis; Pericardium; Pleural Effusion; Pleurisy; Prednisone; Radiography; Respiratory Insufficiency; Streptomycin | 1974 |
Disseminated infection with Mycobacterium avium: I. Clinical features, treatment and pathology.
Topics: Animals; Antitubercular Agents; Child; Drug Resistance, Microbial; Erythromycin; Ethambutol; Female; Gentamicins; Humans; Mycobacterium avium; Mycobacterium tuberculosis; Phenazines; Radiography; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary; United Kingdom | 1968 |
Disseminated infection with Mycobacterium avium: II. Bacteriology and drug susceptibility.
Topics: Amidines; Animals; Antitubercular Agents; Chickens; Cresols; Culture Media; Drug Resistance, Microbial; Erythromycin; Ethambutol; Gentamicins; Guinea Pigs; Mycobacterium tuberculosis; Phenazines; Rabbits; Thiosemicarbazones; Tuberculosis, Avian | 1968 |
[Therapeutic results in lung diseases caused by atypical mycobacteria].
Topics: Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Erythromycin; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1984 |
[Changes in the isoniazid inactivation index during antituberculosis treatment in children].
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Erythromycin; Ethambutol; Humans; Isoniazid; Rifampin; Tuberculosis, Pulmonary | 1983 |
[Extra and intracellular activity of dirithromycin against Mycobacterium avium].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; Ethambutol; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Macrolides; Macrophages; Mycobacterium avium; Rifabutin | 1995 |
[Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Aminosalicylic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Streptomycin; Treatment Refusal | 2001 |
The effect of ethambutol on mycobacterial cell wall permeability to hydrophobic compounds.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cell Membrane Permeability; Cell Wall; Erythromycin; Ethambutol; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Sitosterols | 2005 |